Top Articles

Gynecologic Cancer; Research

Novel Biomarker Might Lead to Personalized, Targeted Therapy

ADP-ribosylation could help scientists predict PARP inhibitor sensitivity in ovarian and breast cancer patients. Learn how UT Southwestern is advancing this research.

Gastrointestinal Cancer; Research

Adjuvant Chemotherapy for Stage III Colon Cancer in Healthy Patients

Researchers at UT Southwestern set out to understand the under-utilization of ACT in stage three colon cancer patients. Learn the impact on patient outcomes here.